Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

81.12
-1.6500-1.99%
Post-market: 81.120.00000.00%19:34 EDT
Volume:403.27K
Turnover:32.99M
Market Cap:3.56B
PE:-74.94
High:83.34
Open:80.89
Low:80.81
Close:82.77
52wk High:91.53
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:0.30
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:10.27
PE(LYR):-51.02

Loading ...

BRIEF-Tarsus Doses First Participant In Calliope, A Phase 2 Clinical Trial Of Tp-05 (Lotilaner)

Reuters
·
Mar 31

Tarsus Pharmaceuticals Inc - Enrollment to Complete in 2026 Tick Season, Topline Results Expected First Half 2027

THOMSON REUTERS
·
Mar 31

Barclays Reaffirms Their Buy Rating on Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Mar 30

Analysts’ Top Healthcare Picks: Tarsus Pharmaceuticals (TARS), IDEAYA Biosciences (IDYA)

TIPRANKS
·
Mar 28

Mizuho Lifts Price Target on Tarsus Pharmaceuticals to $101 From $100, Keeps Outperform Rating

MT Newswires Live
·
Mar 26

Tarsus Pharmaceuticals price target raised to $101 from $100 at Mizuho

TIPRANKS
·
Mar 26

Analysts Conflicted on These Healthcare Names: Cibus (CBUS), Arrowhead Pharmaceuticals (ARWR) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Mar 26

Tarsus COO Neervannan Seshadri disposes of USD 199,516 in common shares

Reuters
·
Mar 25

BUZZ-Tarsus rises as China approval unlocks $15 million milestone for eye drug

Reuters
·
Mar 23

Tarsus TP-03 wins China NMPA approval, triggering USD 15 million milestone payment

Reuters
·
Mar 23

Tarsus Pharmaceuticals Inc - Eligible for Additional Milestones and Tiered Royalties for Tp-03 in Greater China

THOMSON REUTERS
·
Mar 23

Tp-03 (Lotilaner Ophthalmic Solution) 0.25% NOW Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

THOMSON REUTERS
·
Mar 23

Grand Pharmaceutical says China NMPA approves TP-03 for Demodex blepharitis commercialization

Reuters
·
Mar 22

LifeSci Capital Remains a Buy on Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Mar 21

Tarsus Pharmaceuticals Director William J. Link disposed of USD 861,757 of common shares

Reuters
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Mar 17